Polaris Pharmaceuticals-KY Announces Re-election of Chairman
NQ Score
50/100
AI Summary (NQ-processed)
Polaris Pharmaceuticals-KY (stock code 6550) announced on May 15, 2026, that its Board of Directors has re-elected Chen Xian-Zhe as Chairman. The re-election is a result of the expiration of his previous term. The company stated that this event is considered to have a significant impact on shareholder equity or stock prices.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the company code for Polaris Pharmaceuticals-KY?
- A: The company code is 6550.
- Q: Who was elected as the new Chairman?
- A: Chen Xian-Zhe was re-elected as Chairman.
- Q: What was the reason for the change in chairmanship?
- A: The reason was the expiration of the term and subsequent re-election.
- Q: When did the board meeting take place?
- A: The board meeting took place on May 15, 2026.